Represented Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) in its acquisitions of CyDex Pharmaceuticals, Inc., Verrow Pharmaceuticals, Inc., Metabasis Therapeutics, Inc. (Nasdaq: MBRX) and Neurogen Corporation (Nasdaq: NRGN); its acquisitions of over 30 third-party royalties/milestone payments streams from Selexis SA; its strategic alliances with Seelos Therapeutics and Nucorion Pharmaceuticals; and over 30 separate licensing arrangements with global and private pharmaceutical companies.
Represented KonaRed Corporation
in a $2.5 million growth capital financing. Santa-Monica-based Venice Brands, LLC
acted as the primary investor. The transaction involved two new series of convertible preferred stock, 23 different types of warrants, a mechanism for a contingent shift of power to elect a Board majority, two new stock option plans, a management transition with new services agreements, and KonaRed agreeing to “go dark” (elect to cease to be a reporting public company).
Represented Capstone Financial Group, Inc. in the establishment of matching contracts for the purchase and the sale of large numbers of cattle and sheep in Africa and Oman, resulting in a lucrative (9-figures) "middleman" arbitrage position.
Harvard Law School, J.D., 1979, magna cum laude
Yale University, B.A., 1975, magna cum laude
Memberships & Associations
- Past President, San Diego County Bar Association